Bliss GVS Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bliss GVS Pharma Ltd. on BSE

Load latest

Bliss GVS Pharma Ltd.

08 Jul 2025

155.90

-0.20%

Corp. Action

Bliss GVS Pharma Ltd - 506197 - Intimation Of Record Date In Accordance With Regulation 42 …

BSE India

Please find enclosed herewith the Intimation regarding Fixation of Record Date for the payment of Final Dividend for the financial year ended March 31, 2025.

pdf

Bliss GVS Pharma Ltd.

08 Jul 2025

155.90

-0.20%

Company Update

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith the Newspaper Publication regarding 40th Annual General Meeting of the Company.

pdf

Bliss GVS Pharma Ltd.

08 Jul 2025

155.90

-0.20%

Company Update

Bliss GVS Pharma Ltd - 506197 - Communication To Shareholders - Intimation Of Tax Deduction On …

BSE India

Please find enclosed herewith the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.

pdf

Bliss GVS Pharma Ltd.

04 Jul 2025, 07:14PM

155.90

-0.20%

Company Update

Bliss GVS Pharma Ltd - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Please find enclosed the certificate received under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended June 30, 2025.

pdf

Bliss GVS Pharma Ltd.

02 Jul 2025

155.90

-0.20%

Company Update

Bliss GVS Pharma Ltd - 506197 - Disclosure Under Regulation 30 Of Securities And Exchange Board …

BSE India

Please find attached the intimation regarding the Show Cause Notice issued by the Joint Commissioner of CGST and Central Excise, Mumbai.

pdf

Bliss GVS Pharma Ltd.

01 Jul 2025

155.90

-0.20%

SAST

Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gagan Harsh Sharma & PACs

pdf

Bliss GVS Pharma Ltd.

30 Jun 2025

155.90

-0.20%

Company Update

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We would like to inform you that the ESOP Allotment Committee at its meeting held on June 30, 2025, has approved the allotment of 52,000 equity shares of face value Re. 1/- each to the eligible employees who have exercised their stock options under the Bliss GVS Pharma Limited- Employee Stock Option Plan ("Bliss GVS ESOP-2019")

pdf

Bliss GVS Pharma Ltd.

30 Jun 2025

155.90

-0.20%

Company Update

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith the Publication of Notice to Shareholders for Transfer of Unclaimed Final Dividend 2017-2018 and its corresponding shares to IEPF Authority.

pdf

Bliss GVS Pharma Ltd.

30 Jun 2025

155.90

-0.20%

Company Update

Bliss GVS Pharma Ltd - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend …

BSE India

Please find enclosed herewith the Notice sent to the Shareholders of the Company w.r.t. Transfer of Unclaimed Final Dividend 2017-2018 and its corresponding shares to the IEPF Authority.

pdf

Bliss GVS Pharma Ltd.

30 Jun 2025

155.90

-0.20%

SAST

Bliss GVS Pharma Ltd - 506197 - Closure of Trading Window

BSE India

Please find enclosed the Intimation regarding the Closure of the Trading Window w.e.f. July 01, 2025.

pdf

Is Bliss GVS Pharma Ltd. worth buying?

169 Votes:

Buy 81.07%

Sell 8.88%

Hold 10.06%